alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Neurological Disorders and Stroke Special Emphasis Panel. ARRA Supplement Review Panel.                    

*Date:*                         June 26, 2009.                    

*Time:*                         3 p.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         State Plaza Hotel, 2117 E Street, NW., Washington, DC 20037.                    

*Contact Person:*                         Ernest W Lyons, PhD, Scientific Review Administrator, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 20892-9529. 301-496-4056.                         *lyonse@ninds.nih.gov.*

This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences; 93.701, ARRA Related Biomedical Research and Research Support Awards., National Institutes of Health, HHS)

Dated: June 17, 2009.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. E9-14696 Filed 6-22-09; 8:45 am]

BILLING CODE 4140-01-P
<PAGE>
                                                                     EXHIBIT 4.9

                              CERTIFICATE OF TRUST
                                       OF
                       FORD MOTOR COMPANY CAPITAL TRUST II


                  The undersigned Trustees of Ford Motor Company Capital Trust
II (the "Trust"), pursuant to the Delaware Business Trust Act (12 Del. C.
ss.3801, et seq.), HEREBY CERTIFY:

                  1. Name. The name of the business trust formed hereby is Ford
Motor Company Capital Trust II.

                  2. Delaware Trustee. The name and business address of the
Delaware Trustee of the Trust in the State of Delaware is Chase Manhattan Bank
USA, National Association, c/o JPMorgan Chase, Attention: Institutional Trust
Services, 500 Stanton Christiana Road, Floor3/OPS4, Newark, Delaware 19713.

                  IN WITNESS WHEREOF, the undersigned, being all of the Trustees
of the Trust, have executed this Certificate of Trust as of the 30th day of
November, 2001


                                            DELAWARE TRUSTEE:
                                            Chase Manhattan Bank USA,
                                              National Association



                                            By: /s/ John J. Cashin
                                                -----------------------
                                                Name:  John J. Cashin
                                                Title: Vice President




                                            TRUSTEES:

                                            /s/ Douglas J. Cropsey
                                            --------------------------------
                                            Douglas J. Cropsey

                                            /s/ Louis J. Ghilardi
                                            --------------------------------
                                            Louis J. Ghilardi
Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002

In connection with this quarterly report on Form 10-Q of VS Holdings, Inc. (the Company) for the quarter ended
June 28, 2008 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Thomas A. Tolworthy, Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



|(i) | The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and
|--- | -----------------------------------------------------------------------------------------------------------------------------------------



|(ii) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of VS Holdings, Inc.
|---- | ---------------------------------------------------------------------------------------------------------------------------------------------------------

Date: August 12, 2008



/s/ Thomas A. TolworthyThomas A. Tolworthy Chief Executive Officer and Director (Principal Executive Officer)


The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not
being filed as part of this Report.
<PAGE>
 
                                                                    EXHIBIT 23.1

                       [LETTERHEAD OF ERNST & YOUNG LLP]

We consent to the incorporation by reference in the Registration Statement (Form
S-8 No. 333-45697) pertaining to the Equity Incentive Plan and the Employee
Stock Purchase Plan, the Registration Statements (Form S-8 and Form S-3 Nos. 33-
20301 and 33-35198, respectively) pertaining to the 1982 and 1987 Employee Stock
Option Plans, the Registration Statement (Form S-8 No. 33-30578) pertaining to
the 401(k) Plan, the Registration Statement (Form S-8 No. 33-37094) pertaining
to the Employee Stock Purchase Plan, the Registration Statement (Form S-3 No.
33-35129) pertaining to the 1990 Director Stock Option Plan, the Registration
Statement (Form S-3 No. 33-41880) pertaining to the March 1991 private placement
of 1,250,000 units and the Registration Statement (Form S-3) for the
registration of 1,150,000 shares of convertible exchangeable preferred stock, of
our report dated January 28, 1998, with respect to the financial statements of
SEQUUS Pharmaceuticals, Inc. included in this Annual Report (Form 10-K/A) for
the year ended December 31,1997.

Our audits also included the financial statement schedule listed in Item 14(a)
of this Annual Report. This schedule is the responsibility of the Company's
management. Our responsibility is to express an opinion based on our audits. In
our opinion, the financial statement schedule referred to above, when considered
in relation to the basic financial statements taken as a whole, presents fairly
in all material respects the information set forth therein.

                             /s/  ERNST & YOUNG LLP

Palo Alto, California
February 10, 1999
|   | (1)           The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   |   |
|--------|--------|

|   | (2)           The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                      | PORTER BANCORP, INC. |
|---------------------------|----------------------|
|                      |                 |   |
|                      |                 |   |
| Dated:  May 16, 2011 | By:                  | /s/ Maria L. Bouvette |
|                      |                 |  Maria L. Bouvette |
|                      |                 |  Chief Executive Officer |
IV 

116TH CONGRESS 

1ST SESSION H. RES. 95 

Expressing support for designation of February 4, 2019, as National Cancer 

Prevention Day. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 4, 2019 

Mrs. DINGELL (for herself and Mr. UPTON) submitted the following 

resolution; which was referred to the Committee on Energy and Commerce 

RESOLUTION 

Expressing support for designation of February 4, 2019, 

as National Cancer Prevention Day. 

Whereas National Cancer Prevention Day is a day to remind 

us that when looking at cancer we need to look at prevention and reducing risks for human health and the environment; 

Whereas when we work to prevent cancer risks, it impacts 

human health, the environment, and the economy; 

Whereas cancer is one of the leading causes of death around 

the world and has touched the lives of nearly everyone, 

either directly or indirectly; 

Whereas cancer is the cause of nearly 1 out of every 4 deaths 

in the United States; 


kjohnson on DSK79L0C42 with BILLS
2 

•HRES 95 IH 

Whereas in 2019, there will be an estimated 1,762,450 new 

cancer cases diagnosed and 606,880 cancer deaths in the 

United States; 

Whereas cancer is the second most common cause of death 

among children ages 1 to 14 years in the United States 

after accidents, and in 2019 an estimated 11,060 children in this age group will be diagnosed with cancer and 

1,190 will die from it; and 

Whereas February 4, 2019, would be an appropriate date to 

designate as Cancer Prevention Day: Now, therefore, be 

it 

1 Resolved, That the House of Representatives— 

2 (1) supports the designation of National Cancer 

3 Prevention Day; 

4 (2) recognizes all efforts to raise the awareness 

5 for the reduction of cancer risks; and 

6 (3) recognizes the devastating effect cancer has 

7 on families and wishes to expand knowledge, encour8 age early detection, and work with friends in the 

9 medical and scientific fields to put an end to this 

10 deadly disease. 

Æ 


kjohnson on DSK79L0C42 with BILLS
@misc{1212081,
  author = {Dan Kuester and Xifeng Lu and Dazhen Gu and Azizollah Kord and Jake Rezac and Katie Carson and Marla L. Dowell and Elizabeth Eyeson and Ari Feldman and Keith Forsyth and Vu Le and John Marts and Mike McNulty and Kyle Neubarth and Andre Rosete and Matthew Ryan and Maija Teraslina},
  title = {Radio Spectrum Occupancy Measurements Amid COVID-19 Telework and Telehealth},
  year = {2022},
  month = {2022-10-14 04:10:00},
  publisher = {Technical Note (NIST TN), National Institute of Standards and Technology, Gaithersburg, MD},
  url = {https://tsapps.nist.gov/publication/get_pdf.cfm?pub_id=934697},
  doi = {https://doi.org/10.6028/NIST.TN.2240},
  language = {en},
}
@misc{1214961,
  author = {Kevin Stine},
  title = {Norwegian Translation of the Framework for Improving Critical Infrastructure Cybersecurity Version 1.1},
  year = {2023},
  month = {2023-09-19 04:09:00},
  publisher = {NIST International Cybersecurity and Privacy Resources Site},
  url = {https://tsapps.nist.gov/publication/get_pdf.cfm?pub_id=956618},
  doi = {https://doi.org/10.6028/NIST.CSWP.6.nor},
  language = {en},
}
# Third District Court of Appeal

State of Florida

Opinion filed August 2, 2017.

Not final until disposition of timely filed motion for rehearing.

________________

No. 3D17-1024

Lower Tribunal No. 16-10512

________________



### Jerry Ridgeway,

Appellant,

vs.



### The State of Florida

, Appellee.

An Appeal under Florida Rule of Appellate Procedure 9.141(b)(2) from the

Circuit Court for Miami-Dade County, Charles K. Johnson

, Judge.

Jerry Ridgeway

, in proper person.

Pamela Jo Bondi, Attorney General, for appellee.

Before SUAREZ, LAGOA, and FERNANDEZ, JJ.

SUAREZ, J.

Jerry Jerome Ridgeway appeals from the summary denial of his motion to

correct credit for time served. 1 We reverse.

1 A motion seeking additional credit for time served is normally brought pursuant

to Florida Rule of Criminal Procedure 3.801.Ridgeway alleges he was not given proper credit for time served in Texas

and South Carolina while on hold for transfer to Dade County on a fugitive

warrant. There is no evidence in the record before us to show Ridgeway was not

entitled to the credit for time served prior to sentencing that he alleges. But see

Morales v. State

, 970 So. 2d 387 (Fla. 3d DCA 2007) (granting a defendant credit

for time served outside of the state of Florida on unrelated charges, when a warrant

or detainer is issued by this state, is discretionary, not mandatory).

On appeal from a summary denial, this Court must reverse unless the postconviction record shows conclusively that the appellant is entitled to no relief. See

Fla. R. App. P. 9.141(b)(2)(A), (D). Because the record now before us fails to

make the required showing, we reverse the order and remand for further

proceedings. If the trial court again enters an order summarily denying the postconviction motion, the court shall attach record excerpts conclusively showing that

the appellant is not entitled to any relief.

Reversed and remanded for further proceedings.

2
* Pursuant to 5TH CIR. R. 47.5, the court has determined that

this opinion should not be published and is not precedent except

under the limited circumstances set forth in 5TH CIR. R. 47.5.4.

United States Court of Appeals

Fifth Circuit

FILED

August 28, 2006

Charles R. Fulbruge III

Clerk

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 06-40031

Conference Calendar

UNITED STATES OF AMERICA,

Plaintiff-Appellee,

versus

JUAN BLANCO-HERNANDEZ,

Defendant-Appellant.

--------------------

Appeal from the United States District Court

for the Southern District of Texas

USDC No. 1:05-CR-448-ALL

--------------------

Before DAVIS, SMITH, and WIENER, Circuit Judges. 

PER CURIAM:*

Juan Blanco-Hernandez appeals his conviction and the 75-

month sentence imposed following entry of his guilty plea to one

count of being found illegally in the United States subsequent to

deportation and a conviction for an aggravated felony. BlancoHernandez contends that the “felony” and “aggravated felony”

provisions of 8 U.S.C. § 1326(b) are unconstitutional. Because

the Government does not seek to enforce Blanco-Hernandez’s appeal

waiver, it is not binding. See United States v. Story, 439 F.3d

226, 231 (5th Cir. 2006).
No. 06-40031

-2-

Blanco-Hernandez’s constitutional challenge is foreclosed by

Almendarez-Torres v. United States, 523 U.S. 224, 235 (1998). 

Although Blanco-Hernandez contends that Almendarez-Torres was

incorrectly decided and that a majority of the Supreme Court

would overrule Almendarez-Torres in light of Apprendi v. New

Jersey, 530 U.S. 466 (2000), we have repeatedly rejected such

arguments on the basis that Almendarez-Torres remains binding. 

See United States v. Garza-Lopez, 410 F.3d 268, 276 (5th Cir.),

cert. denied, 126 S. Ct. 298 (2005). Blanco-Hernandez properly

concedes that his argument is foreclosed in light of

Almendarez-Torres and circuit precedent, but he raises it here to

preserve it for further review. 

The judgment of the district court is AFFIRMED.
IN THE SUPREME COURT

STATE OF NORTH DAKOTA

2023 ND 5

In the Interest of S.M.B.

Adam D. Miller, PsyD, Petitioner and Appellee

v.

S.M.B., Respondent and Appellant

No. 20220365

Appeal from the District Court of Stutsman County, Southeast Judicial 

District, the Honorable Daniel D. Narum, Judge.

AFFIRMED.

Per Curiam.

Leo A. Ryan, Special Assistant Attorney General, Jamestown, N.D., for

petitioner and appellee; submitted on brief.

Andrew S. Marquart, Fargo, N.D., for respondent and appellant; submitted on 

brief.

FILED 

IN THE OFFICE OF THE 

CLERK OF SUPREME COURT 

JANUARY 5, 2023 

STATE OF NORTH DAKOTA
1

Interest of S.M.B.

No. 20220365

Per Curiam.

[¶1] S.M.B. appeals from an order for continued treatment at the North 

Dakota State Hospital for a period not to exceed one year. S.M.B. argues the 

district court erred in finding him mentally ill and a person requiring 

treatment. We conclude the district court’s findings are supported by clear and 

convincing evidence and are not clearly erroneous. We summarily affirm under 

N.D.R.App.P. 35.1(a)(2).

[¶2] Jon J. Jensen, C.J.

Gerald W. VandeWalle

Daniel J. Crothers

Lisa Fair McEvers

Jerod E. Tufte
[Federal Register Volume 74, Number 125 (Wednesday, July 1, 2009)]
[Notices]
[Page 31450]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-15588]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Center for 
Scientific Review Special Emphasis Panel, July 20, 2009, 8 a.m. to July 
21, 2009, 6 p.m., Ritz Carlton Hotel, 1150 22nd Street, NW., 
Washington, DC, 20037 which was published in the Federal Register on 
June 15, 2009, 74 FR 28260-28262.
    The meeting will be held at the Embassy Suites at the Chevy Chase 
Pavilion, 4300 Military Road, NW., Washington, DC 20015. The meeting 
dates and time remain the same. The meeting is closed to the public.

    Dated: June 22, 2009.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-15588 Filed 6-30-09; 8:45 am]
BILLING CODE 4140-01-M
Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this Quarterly Report on Form 10-Q of Susser Holdings Corporation (the Company) for the three months ended October 3, 2010 as filed with the Securities and Exchange
Commission on the date hereof (the Report), I, Mary E. Sullivan, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act
of 2002 that:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
| | --- | ---------------------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------

Date: November 12, 2010



/s/ Mary E. SullivanMary E. SullivanExecutive Vice President and Chief Financial Officer


This certification accompanies this Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the
extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002

In connection with this quarterly report on Form 10-Q of VS Holdings, Inc. (the Company) for the quarter ended
September 30, 2006 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Cosmo La Forgia, Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



|(i) | The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and
|--- | -----------------------------------------------------------------------------------------------------------------------------------------



|(ii) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of VS Holdings, Inc.
|---- | ---------------------------------------------------------------------------------------------------------------------------------------------------------

Date: November 14, 2006



/s/ Cosmo La ForgiaCosmo La Forgia Vice President of Finance (Principal Financial Officer)


The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not
being filed as part of this Report.
**Exhibit 32**

 

**CertificationPursuant to Section 906 of the Sarbanes-Oxley Act of 2002(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United StatesCode)**

 

Pursuant to Section 906 ofthe Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350,chapter 63 of title 18, United States Code), each of the undersigned officersof Osiris Therapeutics, Inc., (the “Company”), does hereby certify, to the bestof each officer’s knowledge that:

 

The Quarterly Report on Form10-Q for the quarter and nine months ended September 30, 2007 (the “Form 10-Q”)of the Company fully complies with the requirements of Section 13(a) and 15(d)of the Securities Exchange Act of 1934, and the information contained in theForm 10-Q fairly presents, in all material respects, the financial conditionand results of operations of the Company.

 
| Date: November 13, 2007 |   | /s/ C. Randal Mills                      |
|-------------------------|--------|------------------------------------------|
|                    |   | C. Randal Mills, Ph.D.                   |
|                    |   | President & Chief  Executive Officer |
|                    |   |                                     |
| Date: November 13, 2007 |   | /s/ Cary J. Claiborne                    |
|                    |   | Cary J. Claiborne                        |
|                    |   | Chief Financial Officer                  |

 

 

A signed original of thiswritten statement required by Section 906 has been provided to the Company andwill be retained by the Company and furnished to the Securities and ExchangeCommission or its staff upon request.  This certification “accompanies”the Form 10-Q to which it relates, is not deemed filed with the SEC and is notto be incorporated by reference into any filing of the Company under theSecurities Act of 1933, as amended, or the Securities Exchange Act of 1934, asamended (whether made before or after the date of the Form 10-Q), irrespectiveof any general incorporation language contained in such filing.

 

----